Omass Therapeutics Limited
Omass utilizes proprietary biochemistry and native mass spectrometry to explore molecular interactions within their native ecosystems, enhancing drug discovery and development processes.
Founded: 26 Feb 2016
Industries:
72110 - Research and experimental development on biotechnology
Website: omass.com
Phone: +4401157849386
Email: info@omass.com
Location: Oxford
Products & Services
• biochemical analysis tools
• biochemistry
• biochemistry analysis
• biotechnology company
• drug discovery
• drug discovery support
• mass spectrometry
• mass spectrometry services
• molecular interactions
• native mass spectrometry technology
• research institute
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
12
Shareholders
98
Controllers (PSC)
3
Edward Eliot Hodgkin
Director • British • Lives in England • Born in Aug 1963
Christopher Philip Ashton
Director • British • Lives in England • Born in Feb 1960
Magdalena Anna Jonikas
Director • British • Lives in United Kingdom • Born in Apr 1984
Rosamond Margaret Chevallier Deegan
Director • British • Lives in England • Born in Feb 1973
Jonathan Deane Montagu Daoust
Director • British • Lives in Germany • Born in Oct 1975
Registered Office Address
Building 4000 John Smith Drive
Oxford Business Park South
Oxford
OX4 2GX
England
Basic Information
LTD
26 Feb 2016
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
19
Officers
3
PSCs
0
Filings